Increase your confidence in patient stratification
Advances in immuno-oncology (IO) therapies show incredible promise, but variable tissue testing methods, combined with a shortage of tissue samples during early-stage clinical studies, present a major obstacle in realizing the full potential of IO therapies. The Definiens IO-Panel overcomes these problems by offering a standardized assay to profile the immune microenvironment of the tumor.
By eliminating the variables associated with multiple testing kits, the IO-Panel accelerates imaging studies across tissue samples. This service offering combines a validated multiplex immunohistochemistry (IHC) assay with an optimized image and data analysis protocol. Using Definiens Tissue Phenomics®-based approach, the IO-Panel measures expression of seven well-characterized biomarkers to efficiently categorize immune status of tumor samples. High-level results provide a quick and conclusive understanding of the tumor immune status, supported by multiple layers of comprehensive analysis.